Ingredion Incorporated INGR
Set alert
98.93 USD +1.96 +2.02%
At close
98.93 0.00 0.00%
Pre-market · Nov 3, 4:47 AM ET
97.17 Day range 98.95
93.30 52-week range 123.49
- YTD
- -10.28%
- 1 year
- -14.28%
- Open
- 97.50
- Prev close
- 96.97
- Mkt cap
- 6.24B
- Vol
- 680.56K
- Avg vol
- 658.10K
- EPS
- 9.19
- P/E
- 10.77
- Div yield
- 3.42%
More statistics
- Low
- 97.17
- High
- 98.95
- Forward P/E
- 8.81
- Beta
- 0.62
- Short ratio
- 7.04
- Inst. own
- 102.11%
- Dividend
- 3.32
- Ex-div date
- Sep 30, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 98.52
- 200-d avg
- 105.67
- 1y target
- 119.50
MAX chart
Events in this range
- Jan 3, 2007Dividend: 0.09
- Apr 3, 2007Dividend: 0.09
- Oct 2, 2007Dividend: 0.11
- Jan 2, 2008Dividend: 0.11
- Apr 1, 2008Dividend: 0.12
- Jan 6, 2009Dividend: 0.14
- Oct 1, 2012Dividend: 0.26
- Oct 1, 2020Dividend: 0.64
- Oct 1, 2021Dividend: 0.65
- Oct 5, 2022Dividend: 0.71
- Jul 1, 2024Dividend: 0.78
- Oct 1, 2024Dividend: 0.8
- Jan 2, 2025Dividend: 0.8
- Apr 1, 2025Dividend: 0.8
- Jul 1, 2025Dividend: 0.8
- Aug 1, 2025Earnings: 2.87; estimate 2.78; surprise 3.24%
- Oct 1, 2025Dividend: 0.82
- Nov 4, 2025Earnings: 2.75; estimate 2.73; surprise 0.73%
- Jan 2, 2026Dividend: 0.82
- Feb 3, 2026Earnings: 2.53; estimate 2.59; surprise -2.32%
- Apr 1, 2026Dividend: 0.82
- May 5, 2026Earnings: 2.34; estimate 2.44; surprise -4.1%
- May 6, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Jul 1, 2026Dividend: 0.82
- Aug 4, 2026Earnings: 2.82; estimate 2.71; surprise 4.06%
- Aug 5, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Aug 5, 2026Rating: UBS · Neutral → Neutral
- Oct 1, 2026Dividend: 0.83
- Oct 5, 2026Rating: UBS · Neutral → Neutral
Signals (119)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 1, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 1, 2025 | 1 year ago |
| SMA: Bullish | Mar 1, 2025 | 1 year ago |
| SMA: Bearish | Feb 1, 2025 | 1 year ago |
| RSI: Overbought | Nov 1, 2024 | 2 years ago |
| RSI: Overbought | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bearish | Oct 1, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| MACD: Buy Signal | Nov 1, 2022 | 4 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bullish | Oct 1, 2022 | 4 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 1, 2022 | 4 years ago |
Newest 20 of 119.
Analyst view
Consensus: hold
Hold
Price target (mean) 119.50 +20.8% upside
Now 98.93
- Target (low)
- 104.00
- Target (mean)
- 119.50
- Target (high)
- 150.00
Ratings (0m) 7 2 buy · 5 hold · 0 sell
- Strong buy1
- Buy1
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.60 | 2.53 – 2.64 | 2.75 | -5.6% | 1.80B | -0.9% | 6 |
| Next quarter | 2.67 | 2.39 – 2.80 | 2.53 | +5.5% | 1.75B | -0.3% | 6 |
| Current year | 10.46 | 10.16 – 10.63 | 11.13 | -6.1% | 7.20B | -0.3% | 7 |
| Next year | 11.23 | 10.80 – 11.84 | 10.46 | +7.4% | 7.35B | +2.1% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jun 9, 2026 | Oppenheimer | Downgrade | Outperform | Perform |
| May 6, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 17, 2026 | Benchmark | Initiated | — | Buy |
| Feb 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 4, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 4, 2026 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| Nov 6, 2025 | Barclays | Downgrade | Overweight | Equal-Weight |
| Nov 5, 2025 | UBS | Maintained | Neutral | Neutral |
| Nov 5, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Nov 5, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Jul 9, 2025 | UBS | Maintained | Neutral | Neutral |
| Apr 22, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 7, 2025 | UBS | Downgrade | Buy | Neutral |
| Feb 5, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 5, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Feb 5, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Nov 15, 2024 | UBS | Maintained | Buy | Buy |
| Nov 6, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Nov 6, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 6, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 21, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 15, 2024 | UBS | Maintained | Buy | Buy |
| Aug 9, 2024 | Barclays | Upgrade | Equal-Weight | Overweight |
